Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07081945
NA

hAM for Inferior RRD

Sponsor: Eye & ENT Hospital of Fudan University

View on ClinicalTrials.gov

Summary

The objective of the study is to evaluate the efficacy of using hAM patches over the retina to seal inferior retinal breaks. The researchers will evaluate whether hAM patch-assisted vitrectomy improves surgical success rate of retinal reattachment.

Official title: Prospective Study on the Use of Human Amniotic Membrane (hAM) in the Treatment of Inferior Rhegmatogenous Retinal Detachment (RRD)

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2025-08-01

Completion Date

2026-07-31

Last Updated

2025-07-28

Healthy Volunteers

No

Interventions

DEVICE

hAM

The hAM stands for human amniotic membrane, which was used to seal inferior retinal breaks after complete vitrectomy.

Locations (1)

EyeEntFudan

Shanghai, Shanghai Municipality, China